YouTube pioneer reveals stage 4 reclassification and clean post-op scans
November 15, 2026 · 3:25 a.m. Central
Internet personality, comedian, and podcast host Grace Helbig offered an emotional and deeply uplifting health update to her millions of followers, revealing that she is currently living with "No Evidence of Disease" (NED) exactly one month after undergoing urgent brain surgery to excise two metastatic tumors.
In a candid, heartfelt video shared across her digital platforms, the 41-year-old pioneer of early YouTube content explained that because breast cancer cells had migrated into her brain, her medical profile has officially been reclassified as stage 4 metastatic breast cancer, as reported by US Weekly and OncoDaily.
Yet despite the daunting clinical label, Helbig delivered the news with her signature wit and infectious optimism, reassuring fans that recent oncological breakthroughs have transformed how metastatic cancers are managed, turning what was once an immediate death sentence into a navigable chronic illness.
Emergency room visit led to unexpected discovery of two brain tumors
Helbig’s harrowing journey began in early October 2026 when she sought medical evaluation at an emergency room after developing sudden, progressive numbness down her left leg. Initial neurological examinations and rapid MRI imaging uncovered two distinct, operable lesions located on the right side of her brain.
Neurosurgical specialists moved swiftly, admitting her for a craniotomy on October 14, 2026. Surgeons succeeded in completely resecting both masses without inflicting motor or cognitive deficits, according to medical reports summarized by the Daily Mail and Grace Helbig on YouTube.
"The healing has been going genuinely great," Helbig told viewers in her one-month retrospective, showing off her healing surgical incision. "I have full mobility back, my balance is intact, and my cognitive faculties are all firing. It is surreal to look in the mirror and know my brain was operated on just four weeks ago."
'No Evidence of Disease': Embracing targeted therapies and chronic care
Helbig was first diagnosed with stage 2A triple-positive breast cancer in July 2023. At the time, she underwent six grueling cycles of intravenous chemotherapy, a partial mastectomy lumpectomy, targeted radiation treatments, and began long-term hormone suppression therapy, eventually achieving full remission in 2024.
The sudden emergence of secondary brain lesions underscores the tenacious, microscopic nature of triple-positive malignancies. However, follow-up comprehensive PET and MRI scans conducted in November confirmed that following the successful craniotomy, there are zero detectable active tumors anywhere in her body.
"Hearing the term 'Stage 4' is undeniably terrifying, but my oncology team has been extraordinary," Helbig shared. "With the HER2-targeted biologics and brain-penetrating therapies available today, many people live vibrant, long lives for decades managing this as a chronic condition. Right now, I am NED—no evidence of disease—and I am holding on to that victory with everything I have."